New research indicates that individuals who stop using new slimming jabs like semaglutide or tirzepatide tend to recover shed pounds much more quickly than those who halt traditional diet and exercise programs.
Findings released in a leading health publication demonstrates that while overweight individuals often shed substantial amounts of their body weight while using the jabs, the mass comes back at an estimated rate of 0.8 kg per month after stopping.
"Individuals purchasing these drugs must be informed of the danger of quick weight regain when the therapy is stopped," stated lead investigator Dr. Susan Jebb.
Such speed of recovery suggests a reversion to original mass in about one and a half years.
Analyzing Treatments
The study, which looked at 37 of trials involving over 9,000 of patients, contrasted the effects of these new drugs with conventional dieting.
The team point out that people who lose weight through dieting usually experience a more gradual creep back—approximately 100 grams monthly—after stopping.
Explaining the Fast Regain
Nutrition scientists suggest the mechanism of the jabs explains the amplified regain.
These medications copy a natural hormone called glucagon-like peptide-1, which controls hunger.
"Long-term administration of GLP-1 levels far above than the body's typical production may cause the system to produce less of its own natural GLP-1, and could lessen responsiveness to its effects," noted Dr. Adam Collins, a nutrition researcher.
"Stopping of this GLP-1 'fix' means hunger is no longer kept in check, making excessive eating much more probable."
A Lifelong Disease?
Health authorities advise the jabs for people with weight-linked health risks, alongside prescribed diet and exercise modifications.
Professionals contend that, due to the high risk of weight regain, the treatment is often ongoing.
This view is echoed by drug manufacturers, who note that the results "emphasize the long-term character of excess weight," comparing it to managing conditions like hypertension.
User Testimonies
Individuals who have discontinued the jabs explain a intense return of appetite.
"I experienced a switch that goes on and I was suddenly ravenous," recalled an individual.
The struggle is worsened if individuals have not developed permanent dietary or behavioural changes during treatment.
Widespread Adoption
Survey data indicate that a significant number of people in the UK have tried weight-loss jabs in the last 12 months, with demand being substantial.
- Adoption is higher among women compared to men.
- The middle-aged demographic shows the highest level of interest.
- Many obtain the medications through private healthcare rather than the NHS.
Finally, clinicians emphasize that while the jabs are powerful tools for shedding pounds, they are not a magic cure and lasting health benefits relies on ongoing behavioural management.
